PENICILLIN G SODIUM 5 MU

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

BENZYLPENICILLIN SODIUM

Mevcut itibaren:

TEVA ISRAEL LTD

ATC kodu:

J01CE01

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Kompozisyon:

BENZYLPENICILLIN SODIUM 5 MIU/VIAL

Uygulama yolu:

I.M, I.V

Reçete türü:

Required

Tarafından üretildi:

SANDOZ GmbH, AUSTRIA

Terapötik grubu:

BENZYLPENICILLIN

Terapötik alanı:

BENZYLPENICILLIN

Terapötik endikasyonlar:

Infections due to penicillin sensitive organisms.

Yetkilendirme tarihi:

2022-03-31

Bilgilendirme broşürü

ةرفوتملا تامولعملا نم اهرتاوت ديدحت
ناكملإاب سيل :ةفورعم ريغ عويش ةبسن
Acute Generalized Exanthematous Pustulosis –( ممعملا
داحلا يحفطلا راث
ُ
بلا
،ى
ّ
مح ،دلجلا رارمحا نودب وأ عم ءاودلل ة
ّ
داح ةيدلج لعف ة
ّ
در لثم اضارعأ لمشي امب ،)AGEP
.روثبلاب ةهيبش حورج
.)دلجلا ىلع ءارمحو ةحطسم ةقطنم( يطاطح
يعقب حفط
.)ةبصحلا هبشي حفط( يبصح حفط
.ة
ّ
كح
.ىمامح
مفلا ،هجولا ةقطنم يف اصوصخو ،دلجلا تحت
ةجسنأو ةيطاخم ةيشغأ ،دلجلا خافتنا(
ةيئاعو ةمذو
.)ناسللا وأ
.مدلا رثخت صحف تقو لدعم ةلاطإو فيزنلا
تقو ةلاطإ
.)ةيومدلا حئافصلا نم ةضفخنم تايوتسم(
تاحيفصلا صقن
لثم اضارعأ لمشت ،لصملا ضرم مسا اهيلع
قلطي ،مدلا يف تانيتوربلل سسحت طرف لعف
ةدر
.ة
ّ
كح ،نقحلا ةقطنم يف يعضوم رارمحا
،ةيوافمللا دقعلا مروت ،ىمحلا
،ةريرعشقلا ،ةئجافملا ىمحلا للاخ نم
اهزييمت متي يتلا Jarisch-Herxheimer لعف ة
ّ
در
.كاهنلإا وأ/و بعتلا ،لصافملاو تلاضعلا
ملاآ ،سأرلا ملأ ،دلجلا رارمحا
.يضيلأا يغامدلا للاتعلاا
.دبكلا باهتلا
.ةرارملا سيك يف ةرارملا لئاس ق
ّ
فدت صقن
.(pemphigoid( روثبلاب ةبوحصم ةيدلج لكاشم ر
َ
كذ
ُ
ي مل
ّ
يبناج ضرع نم تيناع اذإ وأ ،ةيبناجلا
ضارعلأا نم
ٌّ
يأ مقافت اذإ ،يبناج ضرع رهظ اذإ .بيبطلا ةراشتسا كيلع ،ةرشنلا يف
ة
ّ
يبناجلا ضارعلأا نع غيلبتلا
ضارعلأا نع غلابلإا" طبار ىلع طغضلا ربع
ةيبناجلا ضارعلأاب

Ürün özellikleri

Penicillin-G-Sodium-SPC - Notification 05-2023 N.A
SUMMARY OF PRODUCT CHARACTERISTICS
Penicillin G Sodium 5 MU
Penicillin G Sodium 10 MU
Powder for solution for I.V. or I.M. injection
1.
NAME OF THE MEDICINAL PRODUCT
Penicillin G Sodium 5 MU
Penicillin G Sodium 10 MU
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Penicillin G Sodium 5 MU:
Each vail contains 2.994 g benzylpenicillin sodium, corresponding to
5,000,000 IU.
Sodium content: 8.42 mmol or 193 mg sodium
Penicillin G Sodium 10 MU:
Each vail contains 5.988 g benzylpenicillin sodium, corresponding to
10,000,000 IU.
Sodium content: 16.84 mmol or 386 mg sodium
3.
PHARMACEUTICAL FORM
White to off-white powder for solution for injection.
pH after reconstitution: 5.5 — 7.5
4.
CLINICAL PARTICULARS
4.1. THERAPEUTIC INDICATIONS
Infections due to penicillin - sensitive microorganisms.
4.2. POSOLOGY AND METHOD OF ADMINISTRATION
_Parenteral drug products should be inspected visually for particulate
matter and discoloration, _
_prior to administration, whenever solution and container permit. _
Penicillin G should preferably be administered by intramuscular
injection. However when
large doses are required, it may be advisable to administer Penicillin
G by means of a
continuous intravenous drip.
_Severe infections _
A minimum of 5 MU daily is recommended for the treatment of severe
infections due to
susceptible strains of Streptococci, Pneumococci and Staphylococci
(bacteremia, empyema,
severe pneumonia, pericarditis, endocarditis, meningitis and other
severe infections).
Penicillin-G-Sodium-SPC - Notification 05-2023 N.A
_Anthrax_
A minimum of 5 MU/ day in divided doses, until cure is achieved.
_Actinomycosis _
1-6 MU/ day for cervicofacial cases.
10-20 MU/ day for thoracic and abdominal disease.
_Clostridial infections _
20 MU per day (as adjunctive therapy to antitoxin).
_Diphtheria _
For prevention of the carrier state, 0.3-0.4 MU/ day in divided doses
for 10-12 days.
_Erysipeloid Endocarditis _
2-20 MU/ day for 4-6 weeks.
_Fusospirochetal Infections _
5-10 MU/ day.
_